NCT01735591View on ClinicalTrials.gov

Administration of Probiotics in Cirrhotic Patients Listed for Liver Transplantation

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Liver Cirrhosis
Interventions
DIETARY_SUPPLEMENT

Placebo

Placebo, 1 capsule a day from inclusion until the date of liver transplantation

DIETARY_SUPPLEMENT

Probiotic

Capsules with 3x10\^9 colony forming units of: Lactococcus lactis PB 411 (50%), Lactobacillus casei PB 121 (25%), Lactobacillus acidophilus PB 111 (12,5%), Bifidobacterium bifidum PB 211 (12,5)

Trial Locations (1)

02-097

Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw

All Listed Sponsors
collaborator

Ministry of Science and Higher Education, Poland

OTHER_GOV

lead

Medical University of Warsaw

OTHER

NCT01735591 - Administration of Probiotics in Cirrhotic Patients Listed for Liver Transplantation | Biotech Hunter | Biotech Hunter